分娩住院期间长效可逆避孕措施（LARC）插入的州际差异。
State variations in insertion of long-acting reversible contraception during delivery hospitalization.
机构信息
Division of Reproductive Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Division of Reproductive Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
出版信息
Contraception. 2024 Oct;138:110509. doi: 10.1016/j.contraception.2024.110509. Epub 2024 Jun 1.
OBJECTIVES
This study aimed to describe immediate postpartum long-acting reversible contraception (IPP LARC) insertion rates during delivery hospitalizations at the state level and by payor type.
STUDY DESIGN
This is a cross-sectional study of 26 states and District of Columbia using 2020 State Inpatient Database.
RESULTS
In 2020, IPP LARC insertion rates varied widely by states, ranging from 2.55 to 637.25 per 10,000 deliveries. Rates were higher for deliveries with Medicaid as primary expected payor than with private insurance in all states but District of Columbia.
CONCLUSIONS
Rates of IPP LARC insertion varied in 2020 by state and were higher for deliveries with Medicaid as primary expected payor.
目的
本研究旨在描述州级和支付类型层面分娩住院期间即刻产后长效可逆避孕（IPP LARC）的植入率。
研究设计
这是一项使用 2020 年州住院数据库对 26 个州和哥伦比亚特区进行的横断面研究。
结果
2020 年，IPP LARC 的植入率因州而异，范围从每 10000 次分娩 2.55 到 637.25 次。在所有州（哥伦比亚特区除外），IPP LARC 植入率在 Medicaid 作为主要预期支付方的分娩中均高于私人保险。
结论
2020 年，IPP LARC 的植入率因州而异，在 Medicaid 作为主要预期支付方的分娩中更高。
Zotero 插件